Section 21-2A-04 - Regulations(a) The Secretary, in consultation with the Board, shall adopt regulations to carry out this subtitle.(b) The regulations adopted by the Secretary shall:(1) Specify the prescription monitoring data and naloxone medication data required to be submitted under § 21-2A-03 of this subtitle;(2) Specify the electronic or other means by which information is to be submitted: (i) Without unduly increasing the workload and expense on dispensers; and(ii) In a manner as compatible as possible with existing data submission practices of dispensers;(3) Specify that the information be submitted by dispensers once every 24 hours;(4) Specify that the Program:(i) Shall provide the information technology software to dispensers necessary to upload prescription drug monitoring data and naloxone medication data to the Program; and(ii) May not impose any fees or other assessments on prescribers or dispensers to support the operation of the Program;(5) Identify the mechanism by which:(i) Prescription monitoring data are disclosed to a person, in accordance with § 21-2A-06 of this subtitle; and(ii) Naloxone medication data are disclosed to a person, in accordance with § 21-2A-06.1 of this subtitle;(6) Identify the circumstances under which a person may disclose prescription monitoring data or naloxone medication data received under the Program;(7) Specify the process for the Program's review of prescription monitoring data and naloxone medication data and reporting of:(i) Possible misuse or abuse of a monitored prescription drug under § 21-2A-06(c) of this subtitle; or(ii) A possible violation of law or possible breach of professional standards under § 21-2A-06(d) of this subtitle;(8) Establish requirements for Program retention of prescription monitoring data and naloxone medication data for 3 years; and(9) Require that: (i) Confidential or privileged patient information be kept confidential; and(ii) Records or information protected by a privilege between a health care provider and a patient, or otherwise required by law to be held confidential, be filed in a manner that, except as otherwise provided in §§ 21-2A-06 and 21-2A-06.1 of this subtitle, does not disclose the identity of the person protected.Amended by 2022 Md. Laws, Ch. 224, Sec. 1, eff. 10/1/2022.Amended by 2019 Md. Laws, Ch. 531, Sec. 1, eff. 10/1/2019.Amended by 2016 Md. Laws, Ch. 147, Sec. 2, eff. 10/1/2016.Amended by 2014 Md. Laws, Ch. 651, Sec. 1, eff. 10/1/2014.